A macaque has defied the odds, surviving over a year with a pig kidney transplant in China, marking a groundbreaking achievement in xenotransplantation research. This remarkable feat was announced by scientists from a hospital affiliated with Tongji Medical College at the Huazhong University of Science and Technology, showcasing China's rapid progress in this field.
The success of the experiment, led by Professor Chen Gang, is a significant milestone. It not only demonstrates China's scientific prowess but also provides a solid foundation for future clinical studies in xenotransplantation. This achievement follows closely on the heels of similar breakthroughs in the United States, where research teams have also successfully developed gene-edited donor pigs, enabling organ survival in primates for over a year.
Wang Changxi, a renowned expert in the Chinese Society of Organ Transplantation, emphasizes the country's leadership in this field. Xenotransplantation, a promising solution to the global organ shortage, often utilizes pigs due to their physiological similarity to humans and the ethical considerations surrounding gene editing. However, the primary challenge remains the intense immune rejection across species.
Chen's team has been tackling this challenge since 1999, when they conducted China's first animal xenotransplantation experiment. To overcome the issue of porcine cytomegalovirus, a common virus in gene-edited pigs that often triggers rejection, they sourced specific pathogen-free 'clean pigs' to eliminate the source of danger. Additionally, they developed a comprehensive drug protocol for precise immunosuppression, striking a delicate balance between preventing rejection and avoiding harmful infections.
The need for organ transplants is staggering, with approximately 2 million people worldwide requiring transplants annually, yet only about 10% of patients receive the life-saving procedure. Professor Chen highlights the potential of xenotransplantation for end-stage patients, offering a glimmer of hope for those in dire need of organ transplants.
